To promote greater representation of female healthcare executives in the boardroom by addressing both the supply & demand sides of the equation.
There are more CEOs of large U.S. companies named David (4.5%) than there are CEOs who are women (4.1%)
As of 2017, 7% of VCs are women, and 2% of VC funding goes to female-led companies
There has been progress; in 2017, 36% of open Board seats went to women and 20% to minorities
Oxeon is uniquely positioned to make an impact on this gender gap, particularly in the healthcare VC & PE space
Assistant to the CEO